Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Inadequate Glucose Control”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00481663
What this trial is testing

Different Doses of Sitagliptin (MK-0431) in Participants With Type 2 Diabetes Mellitus (MK-0431-014)

Who this might be right for
Type II Diabetes Mellitus
Merck Sharp & Dohme LLC 555
Large-scale testing (Phase 3)Looking for participantsNCT07394114
What this trial is testing

HDM1005 in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise Alone

Who this might be right for
Type 2 Diabetes
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 240
Large-scale testing (Phase 3)Study completedNCT01381900
What this trial is testing

A Efficacy, Safety, and Tolerability Study of Canagliflozin in Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Alone or in Combination With a Sulphonylurea

Who this might be right for
Diabetes Mellitus, Type 2
Janssen Research & Development, LLC 678
Testing effectiveness (Phase 2)Study completedNCT00789035
What this trial is testing

12 Weeks Treatment With 3 Different Doses of BI 10773 in Type 2 Diabetic Patients

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 408
Large-scale testing (Phase 3)Study completedNCT00094757
What this trial is testing

An Investigational Drug Study in Patients With Type 2 Diabetes Mellitus (MK0431-023)

Who this might be right for
Diabetes Mellitus, Type 2
Merck Sharp & Dohme LLC 521
Large-scale testing (Phase 3)Study completedNCT00509262
What this trial is testing

Sitagliptin Versus Glipizide in Participants With Type 2 Diabetes Mellitus and Chronic Renal Insufficiency (MK-0431-063 AM1)

Who this might be right for
Diabetes Mellitus, Type 2Renal Insufficiency, Chronic
Merck Sharp & Dohme LLC 426
Testing effectiveness (Phase 2)Study completedNCT03645421
What this trial is testing

Safety and Tolerability Study of MEDI0382 in Japanese Preobese or Obese Subjects With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
AstraZeneca 61
Large-scale testing (Phase 3)Study completedNCT00918138
What this trial is testing

Study To Evaluate 24 Hour Blood Sugar Control (24-hour Mean Weighted Glucose) In Subjects That Are Taking Saxagliptin 5 mg Added Onto Metformin XR 1500 XR mg Compared To Subjects Taking Metformin XR 1500 mg Up-titrated To Metformin XR 2000 mg

Who this might be right for
Type 2 Diabetes
AstraZeneca 219
Post-approval studies (Phase 4)Not Yet RecruitingNCT07173712
What this trial is testing

Regimen Transition After Short-Term Intensive Insulin Therapy in Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Yanbing Li 324
Large-scale testing (Phase 3)Study completedNCT02564211
What this trial is testing

Ipragliflozin Add-on Long-term Study in Japanese Participants With Type 2 Diabetes Mellitus on Sitagliptin (MK-0431J-849)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 77
Large-scale testing (Phase 3)Study completedNCT02577016
What this trial is testing

Double-blind Sitagliptin Add-on Study in Japanese Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Ipragliflozin (MK-0431J-842)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 141
Large-scale testing (Phase 3)Study completedNCT01294436
What this trial is testing

Evaluate Safety as Mono or Combination Therapies With Anti-diabetes Mellitus Drugs in Japanese Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Type2 DiabetesHigh Blood Sugar
AstraZeneca 728
Post-approval studies (Phase 4)Study completedNCT00664534
What this trial is testing

Pre-Mix Insulin Lispro Treatment for Type 2 Diabetes Patients Who Consume a Light Breakfast

Who this might be right for
Diabetes Mellitus, Type 2
Eli Lilly and Company 344
Large-scale testing (Phase 3)Study completedNCT01619059
What this trial is testing

Safety and Efficacy of Saxagliptin in Triple Therapy to Treat Subjects With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
AstraZeneca 315
Large-scale testing (Phase 3)Study completedNCT00641043
What this trial is testing

Efficacy vs Placebo as Initial Combination Therapy With Pioglitazone

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 389
Post-approval studies (Phase 4)Study completedNCT02240680
What this trial is testing

Linagliptin as Add on to Basal Insulin in the Elderly

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 302
Large-scale testing (Phase 3)Study completedNCT01294423
What this trial is testing

Evaluate Efficacy and Safety in Japanese Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 DiabetesHigh Blood Sugar
AstraZeneca 261
Testing effectiveness (Phase 2)Study completedNCT00995345
What this trial is testing

Safety and Efficacy of Once-Daily KRP-104 in Type 2 Diabetics With Inadequate Glycemic Control on Metformin Alone

Who this might be right for
Type 2 Diabetes
ActivX Biosciences, Inc. 403
Large-scale testing (Phase 3)Study completedNCT00086515
What this trial is testing

Metformin Add-on Study in Patients With Type 2 Diabetes Mellitus (0431-020)(COMPLETED)

Who this might be right for
Diabetes Mellitus, Type II
Merck Sharp & Dohme LLC 701
Large-scale testing (Phase 3)Ended earlyNCT04754334
What this trial is testing

Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus

Who this might be right for
T2DM (Type 2 Diabetes Mellitus)
Oramed, Ltd. 346
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation